Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $20.59 billion. The enterprise value is $30.88 billion.
| Market Cap | 20.59B |
| Enterprise Value | 30.88B |
Important Dates
The last earnings date was Wednesday, February 11, 2026, before market open.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 87.89 million shares outstanding. The number of shares has decreased by -7.20% in one year.
| Current Share Class | 87.89M |
| Shares Outstanding | 87.89M |
| Shares Change (YoY) | -7.20% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 97.05% |
| Float | 87.19M |
Valuation Ratios
The trailing PE ratio is 15.12 and the forward PE ratio is 13.88. THC's PEG ratio is 1.16.
| PE Ratio | 15.12 |
| Forward PE | 13.88 |
| PS Ratio | 0.99 |
| Forward PS | 0.92 |
| PB Ratio | 4.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.14 |
| P/OCF Ratio | 5.82 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.18, with an EV/FCF ratio of 12.20.
| EV / Earnings | 21.94 |
| EV / Sales | 1.45 |
| EV / EBITDA | 7.18 |
| EV / EBIT | 8.98 |
| EV / FCF | 12.20 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.47.
| Current Ratio | 1.76 |
| Quick Ratio | 1.22 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | 5.21 |
| Interest Coverage | 4.19 |
Financial Efficiency
Return on equity (ROE) is 27.02% and return on invested capital (ROIC) is 15.23%.
| Return on Equity (ROE) | 27.02% |
| Return on Assets (ROA) | 7.33% |
| Return on Invested Capital (ROIC) | 15.23% |
| Return on Capital Employed (ROCE) | 13.64% |
| Weighted Average Cost of Capital (WACC) | 9.48% |
| Revenue Per Employee | $217,449 |
| Profits Per Employee | $14,357 |
| Employee Count | 98,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 35.98 |
Taxes
In the past 12 months, THC has paid $433.00 million in taxes.
| Income Tax | 433.00M |
| Effective Tax Rate | 15.46% |
Stock Price Statistics
The stock price has increased by +75.72% in the last 52 weeks. The beta is 1.44, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +75.72% |
| 50-Day Moving Average | 200.10 |
| 200-Day Moving Average | 185.96 |
| Relative Strength Index (RSI) | 75.00 |
| Average Volume (20 Days) | 1,219,607 |
Short Selling Information
The latest short interest is 2.72 million, so 3.09% of the outstanding shares have been sold short.
| Short Interest | 2.72M |
| Short Previous Month | 2.63M |
| Short % of Shares Out | 3.09% |
| Short % of Float | 3.12% |
| Short Ratio (days to cover) | 3.31 |
Income Statement
In the last 12 months, THC had revenue of $21.31 billion and earned $1.41 billion in profits. Earnings per share was $15.49.
| Revenue | 21.31B |
| Gross Profit | 8.83B |
| Operating Income | 3.44B |
| Pretax Income | 2.80B |
| Net Income | 1.41B |
| EBITDA | 4.30B |
| EBIT | 3.44B |
| Earnings Per Share (EPS) | $15.49 |
Balance Sheet
The company has $2.88 billion in cash and $13.17 billion in debt, with a net cash position of -$10.29 billion or -$117.06 per share.
| Cash & Cash Equivalents | 2.88B |
| Total Debt | 13.17B |
| Net Cash | -10.29B |
| Net Cash Per Share | -$117.06 |
| Equity (Book Value) | 8.97B |
| Book Value Per Share | 48.36 |
| Working Capital | 3.39B |
Cash Flow
In the last 12 months, operating cash flow was $3.54 billion and capital expenditures -$1.01 billion, giving a free cash flow of $2.53 billion.
| Operating Cash Flow | 3.54B |
| Capital Expenditures | -1.01B |
| Free Cash Flow | 2.53B |
| FCF Per Share | $28.79 |
Margins
Gross margin is 41.41%, with operating and profit margins of 16.14% and 6.60%.
| Gross Margin | 41.41% |
| Operating Margin | 16.14% |
| Pretax Margin | 13.14% |
| Profit Margin | 6.60% |
| EBITDA Margin | 20.19% |
| EBIT Margin | 16.14% |
| FCF Margin | 11.87% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.20% |
| Shareholder Yield | 7.20% |
| Earnings Yield | 6.83% |
| FCF Yield | 12.29% |
Analyst Forecast
The average price target for THC is $233.79, which is -0.20% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $233.79 |
| Price Target Difference | -0.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 3.60% |
| EPS Growth Forecast (5Y) | 4.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 1.88 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 6 |